Omeros Earnings per Diluted Share from 2010 to 2024

OMER Stock  USD 3.05  0.16  4.98%   
Check Omeros financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omeros main balance sheet or income statement drivers, such as Depreciation And Amortization of 873.8 K, Selling General Administrative of 34.9 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 12.09, Dividend Yield of 0.0287 or Days Sales Outstanding of 16.24. Omeros financial statements analysis is a perfect complement when working with Omeros Valuation or Volatility modules.
  
This module can also supplement Omeros' financial leverage analysis and stock options assessment as well as various Omeros Technical models . Check out the analysis of Omeros Correlation against competitors.
To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

About Omeros Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Omeros income statement, its balance sheet, and the statement of cash flows. Omeros investors use historical funamental indicators, such as Omeros's Earnings per Diluted Share, to determine how well the company is positioned to perform in the future. Although Omeros investors may use each financial statement separately, they are all related. The changes in Omeros's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Omeros's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Omeros Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Omeros. Please read more on our technical analysis and fundamental analysis pages.
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Omeros Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 213 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:
Check out the analysis of Omeros Correlation against competitors.
To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.
Note that the Omeros information on this page should be used as a complementary analysis to other Omeros' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Omeros Stock analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Omeros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omeros. If investors know Omeros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omeros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
(0.48)
Quarterly Revenue Growth
0.149
Return On Assets
(0.21)
Return On Equity
(5.76)
The market value of Omeros is measured differently than its book value, which is the value of Omeros that is recorded on the company's balance sheet. Investors also form their own opinion of Omeros' value that differs from its market value or its book value, called intrinsic value, which is Omeros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omeros' market value can be influenced by many factors that don't directly affect Omeros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omeros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omeros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omeros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.